HopeStage
Back to all studies
RecruitingNCT07025590

Exercise and antipsychotic dose reduction in heart and mental health care

About this titleRead the official source — NCT07025590
Medication studyAges 18–70ChinaAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
GuangzhouSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 22, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
106
Sponsor
Guangdong Provincial People's Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Behavioural, Drug
Locations
China
Age range
From 18 Years to 70 Years
Official registry ID
NCT07025590
Official title
Show the full official title

Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease: a Multicenter, Randomized Controlled, Non-inferior Clinical Study

Recruitment & locations

Currently recruiting

Guangzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Guangdong Provincial People's Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies